Skip to main content
Fig. 4 | Harm Reduction Journal

Fig. 4

From: Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder

Fig. 4

Incidence proportion (in %) for TEAEs by injection. Proportion of participants reporting treatment-emergent adverse events (TEAEs) by individual BUP-XR maintenance dose injections (1–6). The denominator (shown at the bottom) was the number of participants receiving that injection, and the numerator was the number of participants reporting TEAE between that injection (including the day of injection) and the next injection

Back to article page

Harm Reduction Journal

ISSN: 1477-7517